• Rhön-Klinikum posted H1 2026 revenue up 3.61% to EUR 863.6 million, with EBITDA rising 22.06% to EUR 57 million.
• Consolidated profit climbed 53.06% to EUR 22.5 million, while patients treated increased 9% to 513,700.
• Results reflected transformation costs booked through November 2026 to offset prior-year rises in personnel and material expenses.
• Investments targeted expansion of regional health networks, including a partnership in Hesse and a new child protection emergency service in Frankfurt (Oder).
• Rhön-Klinikum reaffirmed 2026 guidance for revenue of about EUR 1.7 billion ±5% and EBITDA of EUR 110 million to EUR 125 million amid reform-driven uncertainty.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rhön-Klinikum AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2378340_en) on August 06, 2026, and is solely responsible for the information contained therein.